expert roundtables

Promising Lower-Intensity Regimens for Patients With High-Risk MDS and AML
Uncategorized

Promising Lower-Intensity Regimens for Patients With High-Risk MDS and AML

expert roundtables
By Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; Rami S. Komrokji, MD
Metastatic Neuroendocrine Tumors With Carcinoid Syndrome: Individualized Care
Oncology

Metastatic Neuroendocrine Tumors With Carcinoid Syndrome: Individualized Care

expert roundtables
By Jonathan R. Strosberg, MD; Lowell B. Anthony, MD, FACP; Timothy J. Hobday, MD
Diagnosis of Carcinoid Syndrome and Neuroendocrine Tumors
Oncology

Diagnosis of Carcinoid Syndrome and Neuroendocrine Tumors

expert roundtables
By Jonathan R. Strosberg, MD; Lowell B. Anthony, MD, FACP; Timothy J. Hobday, MD
Biologically Targeted Therapies in the Treatment of Mantle Cell Lymphoma
Oncology

Biologically Targeted Therapies in the Treatment of Mantle Cell Lymphoma

expert roundtables
By Anita Kumar, MD; Bijal Shah, MD, MS; Caron A. Jacobson, MD, MMSc
Mantle Cell Lymphoma: Improving Survival in Vulnerable Populations
Oncology

Mantle Cell Lymphoma: Improving Survival in Vulnerable Populations

expert roundtables
By Anita Kumar, MD; Bijal Shah, MD, MS; Caron A. Jacobson, MD, MMSc
Load More